Insider Transactions

What enVVeno Medical Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	1	4
Total trades	1	4

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	11	314
Net activity	−11	−314

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Duhay Francis	Director	Sep 11	Open-market sale · S	−11	$11.21	−$123	2,351
Duhay Francis	Director	Jun 11	Open-market sale · S	−140	$10.31	−$1.44K	2,362
Duhay Francis	Director	Mar 12	Open-market sale · S	−140	$11.52	−$1.61K	2,502
Duhay Francis	Director	Dec 11	Open-market sale · S	−4,900	$0.36	−$1.74K	92,544
Duhay Francis	Director	Sep 15	Open-market sale · S	−4,900	$0.83	−$4.07K	97,444
Gray Robert	Director	Dec 31	Open-market buy · P	+3,500	$2.94	+$10.3K	11,155
Duhay Francis	Director	Dec 31	Open-market buy · P	+81,433	$3.07	+$250K	102,344
Shrivastava Sanjay	Director	Dec 24	Open-market buy · P	+5,400	$2.90	+$15.7K	9,288
Jenusaitis Matthew	Director	Dec 19	Open-market buy · P	+9,620	$2.53	+$24.3K	16,545
Berman Robert Andrew	Chief Executive Officer	Dec 19	Open-market buy · P	+12,000	$2.55	+$30.6K	222,236
Alavi Hamed	Chief Technology Officer	Mar 13	Open-market sale · S	−8,334	$6.22	−$51.8K	0
Alavi Hamed	Chief Technology Officer	Mar 13	Exercise / conversion · M	+8,334	$3.59	+$29.9K	8,334
Gray Robert	Director	Sep 13	Exercise / conversion · M	+1,041	—	—	7,655
Jenusaitis Matthew	Director	Sep 13	Exercise / conversion · M	+1,041	—	—	6,925
Duhay Francis	Director	Aug 16	Open-market buy · P	+7,751	$6.14	+$47.6K	20,911
Shrivastava Sanjay	Director	Jun 30	Open-market buy · P	+1,000	$3.85	+$3.85K	3,888
Berman Robert Andrew	Chief Executive Officer	Jun 27	Open-market buy · P	+2,500	$3.80	+$9.5K	210,236
Berman Robert Andrew	Chief Executive Officer	Nov 30	Grant / award · A	+200,000	—	—	207,736
Glickman Marc H.	SVP & Chief Medical Officer	Nov 30	Grant / award · A	+100,000	—	—	101,600
Glynn Craig	Chief Financial Officer	Nov 30	Grant / award · A	+50,000	—	—	50,000

Page 1 of 4 · showing the 20 most recent Sign up free to view all 72 transactions and filter by insider →

Comments